Patent ID: 8012985

Claim:
A pharmaceutical composition comprising a pharmaceutically effective amount of at least one compound of the formula (I) in which X represents a group of formula (II) where Z is a —(CH 2 ) m group, with m=8 to 21, n=0 or 1 and Y=R 3 , R 1 and R′ 1 , identical to or different from one another, being chosen from H, alkyl, OH, O-alkyl, O-aryl, O—CO-alkyl, O—CO-aryl, OSO 2 -alkyl, OSO 2 -aryl, OSO 2 -heterocycle, O—CO—S-alkyl, O—CO—NH-alkyl, O—CO—O-alkyl, O—CO—O-aryl, O—CO—S-aryl, O—CO—NH-aryl, PO(O-alkyl) 2 , PO(O-aryl) 2 , CO—O—CH 2 -aryl, or cycloalkyl, R 2 and R′ 2 , identical to or different from one another, being chosen from H, alkyl, CO—O—CH 2 -aryl, CO—O-alkyl, or cycloalkyl, R 3 and R′ 3 , identical to or different from one another, representing H, alkyl, CO—O-aryl, COO—CH(R)—O—CO-alkyl, PO(O-alkyl) 2 , PO(O-aryl) 2 , PO(ONa) 2 , or CO—O—CH(R)-aryl, R being H or alkyl, or R 1 and R 2 , and/or R′ 1 and R′ 2 , or R 2 and R 3 and/or R′ 2 and R′ 3 , or R 1 , R 2 and R 3 and/or R′ 1 , R′ 2 and R′ 3 , together form a nitrogenated mono heterocycle with the nitrogen atom or atoms to which they are respectively attached, or, R 2 and R 3 and/or R′ 2 and R′ 3 can be the same substituent, double-bonded to the nitrogen, cyclized with, respectively, R 1 or R′ 1 in order to form a heterocycle, if appropriate substituted by R a , which is chosen from H, alkyl, alkyl substituted by 1, 2 or 3 halogen atoms, aryl, CO—O-alkyl, CO—O-aryl, —CO—OH, —CO—NH 2 , —CN, —CO—NH-alkyl, —CO—NH-aryl, —CO—N-(alkyl) 2 , CO-nitrogenated heterocycle, CO-oxygenated heterocycle, CO-nitrogenated and oxygenated heterocycle, NH 2 , NH-alkyl, N(alkyl) 2 , nitrogenated heterocycle, oxygenated heterocycle, nitrogenated and oxygenated-heterocycle, —O-alkyl, —O-aryl, —O—CH 2 -aryl, CH 2 NH 2 , CH 2 NH-alkyl, CH 2 N-dialkyl, CH 2 NH-aryl, CH 2 -nitrogenated heterocycle, CH 2 -oxygenated heterocycle, CH 2 -nitrogenated and oxygenated heterocycle, CH 2 —CO—OH, or a pharmacologically acceptable salt thereof, in association with an inert pharmaceutical vehicle, with the proviso that when R 1 and R 2 form a heterocycle, and R′ 1 and R′ 2 form the same heterocycle as is formed with R 1 and R 2 , and n=0, and R 3 is hydrogen or alkyl, and R′ 3 is hydrogen or alkyl, or when R 1 and R 3 form a heterocycle, and R′ 1 and R′ 3 form the same heterocycle as is formed with R 1 and R 3 , and n=0, and R 2 is hydrogen or alkyl, and R′ 2 is hydrogen or alkyl, then m is 12-21.